User profiles for Eduardo N. Chini

Eduardo Chini

Professor of Pharmacology
Verified email at mayo.edu
Cited by 10753

[PDF][PDF] CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism

J Camacho-Pereira, MG Tarragó, CCS Chini, V Nin… - Cell metabolism, 2016 - cell.com
Nicotinamide adenine dinucleotide (NAD) levels decrease during aging and are involved in
age-related metabolic decline. To date, the mechanism responsible for the age-related …

Targeting senescent cells alleviates obesity‐induced metabolic dysfunction

…, M Ogrodnik, D Jurk, MD Jensen, EN Chini… - Aging cell, 2019 - Wiley Online Library
Adipose tissue inflammation and dysfunction are associated with obesity‐related insulin
resistance and diabetes, but mechanisms underlying this relationship are unclear. Although …

Cellular senescence in type 2 diabetes: a therapeutic opportunity

AK Palmer, T Tchkonia, NK LeBrasseur, EN Chini… - Diabetes, 2015 - Am Diabetes Assoc
Cellular senescence is a fundamental aging mechanism that has been implicated in many
age-related diseases and is a significant cause of tissue dysfunction. Accumulation of …

Regulation of intracellular levels of NAD: a novel role for CD38

P Aksoy, TA White, M Thompson, EN Chini - Biochemical and biophysical …, 2006 - Elsevier
Nicotinamide adenine dinucleotide (NAD) plays key roles in many cellular functions. In addition
to its well-known role in energy metabolism, NAD also plays a role in signal transduction…

Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome

…, L O'Neil, TA White, DA Sinclair, EN Chini - Diabetes, 2013 - Am Diabetes Assoc
Metabolic syndrome is a growing health problem worldwide. It is therefore imperative to
develop new strategies to treat this pathology. In the past years, the manipulation of NAD + …

CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels

CCS Chini, TR Peclat, GM Warner, S Kashyap… - Nature …, 2020 - nature.com
Decreased NAD + levels have been shown to contribute to metabolic dysfunction during
aging. NAD + decline can be partially prevented by knockout of the enzyme CD38. However, it …

[HTML][HTML] The multi-faceted ecto-enzyme CD38: roles in immunomodulation, cancer, aging, and metabolic diseases

KA Hogan, CCS Chini, EN Chini - Frontiers in immunology, 2019 - frontiersin.org
CD38 (Cluster of Differentiation 38) is a multifunctional ecto-enzyme that metabolizes NAD+
and mediates nicotinamide dinucleotide (NAD+) and extracellular nucleotide homeostasis …

[PDF][PDF] A potent and specific CD38 inhibitor ameliorates age-related metabolic dysfunction by reversing tissue NAD+ decline

MG Tarragó, CCS Chini, KS Kanamori, GM Warner… - Cell metabolism, 2018 - cell.com
Aging is characterized by the development of metabolic dysfunction and frailty. Recent studies
show that a reduction in nicotinamide adenine dinucleotide (NAD + ) is a key factor for the …

Abscisic acid controls calcium-dependent egress and development in Toxoplasma gondii

K Nagamune, LM Hicks, B Fux, F Brossier, EN Chini… - Nature, 2008 - nature.com
Calcium controls a number of critical events, including motility, secretion, cell invasion and
egress by apicomplexan parasites 1 . Compared to animal 2 and plant cells 3 , the molecular …

CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions

EN Chini - Current pharmaceutical design, 2009 - ingentaconnect.com
CD38 is a multifunctional enzyme that uses nicotinamide adenine dinucleotide (NAD) as a
substrate to generate second messengers. Recently, CD38 was also identified as one of the …